EMA Authorised: Levetiracetam Accord (levetiracetam) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Levetiracetam Accord for epilepsy, granting EU marketing authorization to Accord Healthcare S.L.U.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Levetiracetam Accord (levetiracetam)

Snippet

Status: Authorised. Therapeutic area: Epilepsy. MAH: Accord Healthcare S.L.U.. Decision date: 09/12/2025